Simris Group AB Logo

Simris Group AB

Develops novel cyanobacteria-based payloads for Antibody-Drug Conjugates to treat cancer.

SIMRIS | ST

Overview

Corporate Details

ISIN(s):
SE0008091656 (+1 more)
LEI:
529900P0ACIS2UI3ZX27
Country:
Sweden
Address:
Herrestadsvägen 24A, 276 50 HAMMENHÖG
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Simris Group AB is a biotechnology company specializing in the development of next-generation payloads for Antibody-Drug Conjugates (ADCs) to advance cancer treatment. The company leverages its proprietary platform, which is built upon the world's largest cyanobacterial strain library and deep expertise in bioconjugation technologies. Simris engineers and develops novel, IP-protected payloads using cyanobacterial toxin engineering. These payloads are designed to improve the therapeutic window of ADCs by enhancing their potency, safety, and selectivity compared to conventional options, with the goal of revolutionizing the therapeutic potential of ADC treatments in oncology.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Simris Group AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Simris Group AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
FARON PHARMACEUTICALS OY Logo
Develops myeloid cell-targeting immunotherapies for solid and hematological cancers.
Finland FARN
Fluicell AB Logo
Developing bioprinted tissues for regenerative medicine and advanced drug screening.
Sweden FLUI
FluoGuide A/S Logo
Develops fluorescent drugs to guide surgeons for more precise cancer removal and patient outcomes.
Denmark FLUO
FUSION ANTIBODIES PLC Logo
A CRO providing end-to-end antibody engineering services for therapeutic & diagnostic development.
United Kingdom FAB
FUTURA MEDICAL PLC Logo
Develops topical sexual health gels, including a fast-acting, over-the-counter ED treatment.
United Kingdom FUM
GENINCODE PLC Logo
AI-powered genetic tests for physicians, predicting and preventing cardiovascular disease.
United Kingdom GENI
Genomic Vision Logo
Develops DNA analysis tools using Molecular Combing for genetic research and diagnostics.
France GV
Genxone Spolka Akcyjna Logo
A biotech firm offering nanopore DNA/RNA sequencing services and medical diagnostics.
Poland GX1
Hamlet BioPharma AB Logo
Developing selective therapies for cancer and infections like bladder cancer and UTIs.
Sweden HAMLET
Hipower Energy Spolka Akcyjna Logo
Develops hydrogen solutions, mobile refueling, and CO2-to-methanol tech for energy markets.
Poland HPE

Talk to a Data Expert

Have a question? We'll get back to you promptly.